Raise awareness in psychiatrists about Abilify® as it was being introduced in the Netherlands. Specific questions that were adressed include:
* What type of patient could benefit the most from this antipsychotic?
* What are the expected effects of treatment?
* What are the possible side-effects and how can they best be addressed?